Edition:
United States

Recordati Industria Chimica e Farmaceutica SpA (RECI.MI)

RECI.MI on Milan Stock Exchange

26.00EUR
9 Dec 2016
Change (% chg)

€0.47 (+1.84%)
Prev Close
€25.53
Open
€25.55
Day's High
€26.11
Day's Low
€25.20
Volume
658,472
Avg. Vol
457,857
52-wk High
€29.74
52-wk Low
€19.08

Latest Key Developments (Source: Significant Developments)

Recordati signs license agreement with Richter to commercialize cariprazine
Tuesday, 2 Aug 2016 02:00am EDT 

Recordati Industria Chimica e Farmaceutica SpA : Signs a license agreement with Gedeon Richter (Richter) to commercialize cariprazine in Western Europe and in Algeria, in Tunisia and in Turkey . The European Medicines Agency (EMA) started the evaluation of Richter's marketing authorization application for cariprazine, an atypical antipsychotic, for the treatment of schizophrenia in March . Recordati to make an upfront payment and further milestone payments depending on the progress of both the regulatory procedure and the product commercialization . Further sales-related royalties will become payable to Richter following the launch of the product .Richter to be responsible for conducting pediatric clinical studies according to the Pediatric Investigation Plan, as required by the European Medicines Agency's PDCO (Pediatric Committee) and it shall be co-financed with Recordati.  Full Article

Recordati H1 net profit jumps at EUR 122.7 mln
Thursday, 28 Jul 2016 06:05am EDT 

Recordati Industria Chimica E Farmaceutica SpA : H1 net profit 122.7 million euros ($136.07 million) versus 103.2 million euros a year ago, up 18.9 percent .H1 net revenues 587.9 million euros versus 539.1 million euros a year ago, up 9.1 percent.  Full Article

Recordati buys 100 pct stake in Swiss pharmaceutical company Pro Farma
Thursday, 14 Jul 2016 06:31am EDT 

Recordati Industria Chimica e Farmaceutica SpA : Announces acquisition of 100 percent of share capital of Pro Farma AG, a swiss pharmaceutical company .Value of transaction (enterprise value) is of 16 million Swiss francs ($16.31 million) and will be funded from existing liquidity.  Full Article

Italy's Recordati buys Italchimici in deal valued at 130 mln euros
Tuesday, 31 May 2016 10:05am EDT 

Italy's Recordati Industria Chimica E Farmaceutica says: has bought all of Italian pharmaceutical company Italchimici . deal valued at about 130 million euros .to be funded in cash.  Full Article

Recordati Industria Chimica E Farmaceutica SpA proposes dividend on 2015 of 0.60 euros per share
Tuesday, 8 Mar 2016 08:04am EST 

Recordati Industria Chimica E Farmaceutica SpA:Proposes dividend on 2015 of 0.60 euro per share, of which 0.30 euro already paid.  Full Article

Recordati Industria Chimica e Farmaceutica SpA confirms FY 2015 outlook in line with analysts' estimates, proposes interim 2015 dividend
Wednesday, 28 Oct 2015 07:21am EDT 

Recordati Industria Chimica e Farmaceutica SpA:Confirms to achieve FY 2015 sales of around 1.04 billion euros.Confirms FY 2015 operating income of around 270 million euros.Confirms FY 2015 net income of around 190 million euros.Reported FY 2014 revenue at 987.4 million euros.Reported FY 2014 operating profit at 231.0 million euros.Reported FY 2014 net profit of 161.2 million euros.FY 2015 revenue of 1.04 billion euros - Thomson Reuters I/B/E/S.FY 2015 operating profit of 273.1 million euros - Thomson Reuters I/B/E/S.FY 2015 net profit of 193.9 million euros - Thomson Reuters I/B/E/S.Proposes 2015 interim dividend of 0.30 euros per share.  Full Article

Recordati Industria Chimica E Farmaceutica SpA: unit says Canada grants market authorization for Carbaglu
Tuesday, 8 Sep 2015 08:00pm EDT 

Recordati Industria Chimica E Farmaceutica SpA:Company's unit Orphan Europe says Health Canada has granted market authorization for Carbaglu.Authorization for Carbaglu was granted as an adjunctive therapy for the treatment of acute hyperammonemia (high blood level of ammonia) or as a maintenance therapy for chronic hyperammonemia due to the deficiency of the hepatic enzyme N-aceytlglutamate synthase (NAGS) in pediatric and adult patients.Carbaglu will be imported and distributed in Canada by unit Recordati Rare Diseases Inc.  Full Article

Recordati Industria Chimica e Farmaceutica SpA reviews FY 2015 targets upwards
Wednesday, 29 Jul 2015 05:04am EDT 

Recordati Industria Chimica e Farmaceutica SpA:"The group's business performance during July was in line with the first half and consequently targets for the full year 2015 were reviewed upwards of those announced on 12 February 2015" - CEO and chairman Giovanni Recordati.Expects FY 2015 sales of around 1,040 million euros.Expects FY 2015 operating income of around 270 million euros.Expects FY 2015 net income of around 190 million euros.Reported FY 2014 net profit of 161.20 million euros.FY 2015 net profit of 191.32 million euros - Thomson Reuters I/B/E/S.  Full Article

Recordati Industria Chimica E Farmaceutica SpA reaffirms FY 2015 revenue guidance
Tuesday, 5 May 2015 05:32am EDT 

Recordati Industria Chimica E Farmaceutica SpA:Reaffirms FY 2015 revenue of over 1 billion euros.FY 2015 revenue of 1.04 billions - Thomson Reuters I/B/E/S.  Full Article

Recordati Industria Chimica E Farmaceutica SpA proposes FY 2014 dividend
Wednesday, 4 Mar 2015 06:47am EST 

Recordati Industria Chimica E Farmaceutica SpA:Proposes FY 2014 dividend of 0.50 euro per share, of which 0.26 euro per share has already been paid (FY 2013: 0.33 euro per share).FY 2014 dividend to be paid on April 22, and record date on April 21.  Full Article

UPDATE 1-Recordati names new CEO after death of Giovanni Recordati

MILAN, Aug 16 Italian drugmaker Recordati appointed Andrea Recordati as its new chief executive on Tuesday following the death of his 66-year-old step-brother Giovanni after a long illness.